"We are excited to be working with the Nanosphere team to bring these innovative molecular diagnostic products to our customers for the first time. Together with our existing range of Thermo Scientific microbiology products, they provide a comprehensive solution to diagnosis of serious infectious disease." -- Thermo Fisher
Thermo Fisher Scientific does roughly $12 billion per year in revenue and has an approximate $20 billion market value. Nanosphere's market value is currently $73 million.
Nanosphere (NSPH) releases 1Q'12 results tomorrow (02012.05.01).
[update::02012.05.01] NSPH closed yesterday at $1.78, up 6.6% for the day. Trading volume was light.
[update::02012.05.01] Nanosphere released 1Q'12 results prior to the market opening today. 1Q'12 revenues were double those for 1Q'11 and these days Nanophere needs to generate some revenue. The company ended the quarter with ~$0.73 per share in cash. The number of shares outstanding at the end of 1Q'12 was ~58% higher than at the end of 1Q'11. Again, NSPH closed yesterday at $1.78.
"Our business has achieved an inflection point with new customer placements that will drive significant revenue growth in 2012," commented William Moffitt, Nanosphere's president and chief executive officer.